• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人的心房颤动:概念与争议

Atrial Fibrillation in Older People: Concepts and Controversies.

作者信息

Zathar Zafraan, Karunatilleke Anne, Fawzy Ameenathul M, Lip Gregory Y H

机构信息

Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom.

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.

出版信息

Front Med (Lausanne). 2019 Aug 8;6:175. doi: 10.3389/fmed.2019.00175. eCollection 2019.

DOI:10.3389/fmed.2019.00175
PMID:31440508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6694766/
Abstract

Atrial fibrillation (AF) is the commonest cardiac rhythm abnormality and has a significant disease burden. Amongst its devastating complications is stroke, the risk of which increases with age. The stroke risk in an older person with AF is therefore tremendous, and oral-anticoagulation (OAC) therapy is central to minimizing this risk. The presence of age-associated factors such as frailty and multi-morbidities add complexity to OAC prescription decisions in older patients and often, OAC is needlessly withheld from them despite a lack of evidence to support this practice. Generally, this is driven by an over-estimation of the bleeding risk. This review article provides an overview of the concepts and controversies in managing AF in older people, with respect to the existing evidence and current practice. A literature search was conducted on Pubmed and Cochrane using keywords, and relevant articles published by the 1st of May 2019 were included. The article will shed light on common misconceptions that appear to serve as rationale for precluding OAC and focus on clinical considerations that may aid OAC prescription decisions where appropriate, to optimize AF management using an integrated, multi-disciplinary care approach. This is crucial for all patients, particularly older individuals who are most vulnerable to the deleterious consequences of this condition.

摘要

心房颤动(AF)是最常见的心律失常,具有重大的疾病负担。其严重并发症之一是中风,中风风险会随着年龄增长而增加。因此,老年房颤患者的中风风险极大,口服抗凝(OAC)治疗对于将这种风险降至最低至关重要。诸如虚弱和多种疾病等与年龄相关的因素增加了老年患者OAC处方决策的复杂性,而且尽管缺乏支持这种做法的证据,但老年患者往往被不必要地停用OAC。一般来说,这是由于对出血风险的高估所致。这篇综述文章根据现有证据和当前实践,概述了老年房颤管理中的概念和争议。使用关键词在PubMed和Cochrane上进行了文献检索,并纳入了截至2019年5月1日发表的相关文章。本文将阐明那些似乎作为排除OAC理由的常见误解,并重点关注在适当情况下可能有助于OAC处方决策的临床考量因素,以采用综合、多学科护理方法优化房颤管理。这对所有患者都至关重要,尤其是那些最易受这种疾病有害后果影响的老年人。

相似文献

1
Atrial Fibrillation in Older People: Concepts and Controversies.老年人的心房颤动:概念与争议
Front Med (Lausanne). 2019 Aug 8;6:175. doi: 10.3389/fmed.2019.00175. eCollection 2019.
2
Assessing the Appropriateness of Oral Anticoagulation for Atrial Fibrillation in Advanced Frailty: Use of Stroke and Bleeding Risk-Prediction Models.评估老年衰弱患者心房颤动口服抗凝治疗的适宜性:卒中与出血风险预测模型的应用
J Frailty Aging. 2017;6(1):46-52. doi: 10.14283/jfa.2016.118.
3
Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis.老年人衰弱相关心房颤动的管理:系统评价和荟萃分析。
Age Ageing. 2019 Mar 1;48(2):196-203. doi: 10.1093/ageing/afy180.
4
What is the Impact of Frailty on Prescription of Anticoagulation in Elderly Patients with Atrial Fibrillation? A Systematic Review and Meta-Analysis.衰弱对老年房颤患者抗凝治疗处方有何影响?一项系统评价和荟萃分析。
J Atr Fibrillation. 2018 Apr 30;10(6):1870. doi: 10.4022/jafib.1870. eCollection 2018 Apr.
5
Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry.治疗 90 岁以上老年人的心房颤动:来自柏林心房颤动(BAF)登记研究的见解。
J Am Med Dir Assoc. 2015 Nov 1;16(11):969-72. doi: 10.1016/j.jamda.2015.05.012. Epub 2015 Jun 27.
6
Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.具有高卒中及出血风险的房颤患者的口服抗凝治疗
Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):177-94. doi: 10.1016/j.pcad.2015.07.003. Epub 2015 Jul 7.
7
Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.急性缺血性卒中后老年房颤患者口服抗凝治疗的应用
J Am Geriatr Soc. 2017 Feb;65(2):241-248. doi: 10.1111/jgs.14688. Epub 2016 Dec 30.
8
Contraindications for anticoagulation in older patients with atrial fibrillation; a narrative review.老年房颤患者抗凝治疗的禁忌证;一项叙述性综述。
Curr Drug Saf. 2010 Jul 2;5(3):223-33. doi: 10.2174/157488610791698253.
9
Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.开发一种共享决策工具,以协助患者和临床医生就心房颤动的口服抗凝治疗做出决策。
Curr Med Res Opin. 2015 Dec;31(12):2261-72. doi: 10.1185/03007995.2015.1096767. Epub 2015 Oct 22.
10
Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.衰弱和认知障碍与口服抗凝药在房颤患者中的获益的关系。
Am Heart J. 2019 May;211:77-89. doi: 10.1016/j.ahj.2019.01.005. Epub 2019 Jan 30.

引用本文的文献

1
Unsupervised Clustering of Patients Undergoing Thoracoscopic Ablation Identifies Relevant Phenotypes for Advanced Atrial Fibrillation.接受胸腔镜消融治疗患者的无监督聚类识别出晚期心房颤动的相关表型。
Diagnostics (Basel). 2025 May 16;15(10):1269. doi: 10.3390/diagnostics15101269.
2
Emergency Department Serum Electrolyte Patterns in Paroxysmal Atrial Fibrillation.阵发性心房颤动患者急诊科血清电解质模式
J Clin Lab Anal. 2025 Apr;39(8):e70030. doi: 10.1002/jcla.70030. Epub 2025 Apr 7.
3
Parameter Predicting Postoperative Atrial Fibrillation in Coronary Artery Bypass Grafting Patients: Triglyceride-Cholesterol-Body Weight Index.冠状动脉搭桥手术患者术后房颤的预测参数:甘油三酯-胆固醇-体重指数
Arq Bras Cardiol. 2025 Mar 31;122(4):e20240607. doi: 10.36660/abc.20240607. eCollection 2025.
4
Impact of frailty on outcomes of elderly patients with atrial fibrillation: A systematic review and meta-analysis.衰弱对老年房颤患者预后的影响:一项系统评价和荟萃分析。
Pak J Med Sci. 2025 Mar;41(3):891-901. doi: 10.12669/pjms.41.3.11357.
5
Outcomes and Disease Management in Patients With Atrial Fibrillation ≥80 Years: Data From a Consecutive 11-Year Real-World Registry.80岁及以上心房颤动患者的结局与疾病管理:来自连续11年真实世界注册研究的数据
J Am Heart Assoc. 2025 Feb 18;14(4):e036832. doi: 10.1161/JAHA.124.036832. Epub 2025 Feb 8.
6
Assessment of Knowledge and Medication Adherence Among Patients Prescribed with Oral Anticoagulants in Atrial Fibrillation at a Tertiary Care Centre: A Cross Sectional Study.三级医疗中心心房颤动患者口服抗凝剂知识与用药依从性评估:一项横断面研究
J Blood Med. 2024 Dec 20;15:533-547. doi: 10.2147/JBM.S493313. eCollection 2024.
7
Patient Characteristics and Real-World Treatment of Very Elderly Patients with Nonvalvular Atrial Fibrillation in Japan: An Administrative Claims Database Study.日本非瓣膜性心房颤动高龄患者的患者特征及真实世界治疗:一项行政索赔数据库研究
Cardiol Ther. 2025 Mar;14(1):31-52. doi: 10.1007/s40119-024-00392-3. Epub 2024 Dec 23.
8
Correlation between triglyceride-glucose index and atrial fibrillation in acute coronary syndrome patients: a retrospective cohort study and the establishment of a LASSO-Logistic regression model.急性冠状动脉综合征患者甘油三酯-葡萄糖指数与心房颤动的相关性:一项回顾性队列研究及LASSO-Logistic回归模型的建立
BMC Cardiovasc Disord. 2024 Dec 5;24(1):702. doi: 10.1186/s12872-024-04385-x.
9
The association between alcohol intake and incident atrial fibrillation in older adults: The ARIC cohort.酒精摄入与老年人房颤事件的关联:ARIC 队列研究。
PLoS One. 2024 Nov 21;19(11):e0314207. doi: 10.1371/journal.pone.0314207. eCollection 2024.
10
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients.老年患者卵圆孔未闭封堵术后不良结局的决定因素。
EuroIntervention. 2024 Aug 19;20(16):1029-1038. doi: 10.4244/EIJ-D-24-00156.

本文引用的文献

1
Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.衰弱和认知障碍与口服抗凝药在房颤患者中的获益的关系。
Am Heart J. 2019 May;211:77-89. doi: 10.1016/j.ahj.2019.01.005. Epub 2019 Jan 30.
2
Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week.心房颤动与认知功能:JACC 每周综述专题。
J Am Coll Cardiol. 2019 Feb 12;73(5):612-619. doi: 10.1016/j.jacc.2018.10.077.
3
Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review.改善心房颤动患者口服抗凝药物的处方:系统评价。
Thromb Haemost. 2019 Feb;119(2):294-307. doi: 10.1055/s-0038-1676835. Epub 2019 Jan 22.
4
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study.ABC(心房颤动更好的护理)路径与心房颤动的医疗成本:ATHERO-AF 研究。
Am J Med. 2019 Jul;132(7):856-861. doi: 10.1016/j.amjmed.2019.01.003. Epub 2019 Jan 16.
5
Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.心房颤动和心血管事件风险患者的综合护理管理:ATHERO-AF 研究队列中的 ABC(心房颤动更好护理)途径。
Mayo Clin Proc. 2019 Jul;94(7):1261-1267. doi: 10.1016/j.mayocp.2018.10.022. Epub 2018 Dec 11.
6
Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation: A Balance of Evidence, Practicality and Precision.优化心房颤动患者的卒中与出血风险评估:证据、实用性与精准性的平衡
Thromb Haemost. 2018 Dec;118(12):2014-2017. doi: 10.1055/s-0038-1676074. Epub 2018 Nov 20.
7
Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle.心房颤动治疗的持久性:下一个主要障碍。
Thromb Haemost. 2018 Dec;118(12):2018-2019. doi: 10.1055/s-0038-1676101. Epub 2018 Nov 19.
8
Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis.老年人衰弱相关心房颤动的管理:系统评价和荟萃分析。
Age Ageing. 2019 Mar 1;48(2):196-203. doi: 10.1093/ageing/afy180.
9
Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.在房颤的 CHA2DS2-VASc 评分中是否应该量化冠状动脉疾病的存在或程度?来自丹麦西部心脏注册中心的报告。
Thromb Haemost. 2018 Dec;118(12):2162-2170. doi: 10.1055/s-0038-1675401. Epub 2018 Nov 12.
10
Oral anticoagulants and risk of dementia: A systematic review and meta-analysis of observational studies and randomized controlled trials.口服抗凝剂与痴呆风险:观察性研究和随机对照试验的系统评价和荟萃分析。
Neurosci Biobehav Rev. 2019 Jan;96:1-9. doi: 10.1016/j.neubiorev.2018.10.025. Epub 2018 Nov 2.